Stephen Rosen

Cooley advised the shareholders of ICS Learn, an online professional education platform owned by private equity firm Primary Capital Partners, on the platform’s sale to vocational e-learning provider Skill & You, a portfolio company of private equity firm IK Partners. Private equity partner Stephen Rosen led the Cooley team advising the shareholders of ICS Learn.

Cooley advised Eliem Therapeutics on its $92 million initial public offering of 7,360,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Eliem Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol ELYM, is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Partners Alan Hambelton, Sonya Erickson and Stephen Rosen led the Cooley team.

Advising Primary Capital on its significant investment in Sigma Sports, the UK’s leading premium omni-channel retailer of cycling equipment. 

Cooley advised the management team of CSL, an international critical communications service provider, on its significant investment from private equity firm ECI Partners. Cooley partner Stephen Rosen led the team advising CSL on the transaction.

Cooley advised Battery Ventures on its acquisition of Guardsquare, a fast-growing and market leading security company focused on protecting complex mobile applications run by rapidly transforming enterprises across industries. Partner Stephen Rosen led the Cooley team.